Osteoporosis Management Strategies

Friday, March 31, 2023

5:00 PM – 6:00 PM

Location: Winnetka

*Speaker(s)

Angela M. Cheung, MD, PhD, FRCPC (she/her/hers)

Professor of Medicine
University of Toronto, CANADA, Canada

Disclosure(s): Alexion / Astra Zeneca: Consulting Fee (e.g., Advisory Boards) (Ongoing); Amgen Canada: Consulting Fee (e.g., Advisory Boards) (Ongoing)

*Moderator(s)

Jad G. Sfeir, MD, MS (he/him/his)

Assistant Professor of Medicine
Mayo Clinic

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Angela M. Cheung, MD, PhD, FRCPC: Alexion / Astra Zeneca: Consulting Fee (e.g., Advisory Boards) (Ongoing); Amgen Canada: Consulting Fee (e.g., Advisory Boards) (Ongoing)

Jad G. Sfeir, MD, MS: No financial relationships to disclose

This session will describe the evidence behind optimal strategies in osteoporosis management, including optimal pharmacologic sequences and the role of combination therapy, as well as optimal treatment targets.

Learning Objectives:

Describe various strategies in the longitudinal management of osteoporosis.
Identify optimal pharmatherapeutic sequences for fracture risk reduction.
Discuss optimal targets in osteoporosis care.